As Adarza scales up, St. Louis hopes for an important win. By David Nicklaus
RiverVest leads $17 million investment in Adarza, brings on new president
ROCHESTER, NY and ST LOUIS, MO (Jan. 19, 2017) – Adarza BioSystems, Inc., a leading next generation innovator in label-free, multiplex assays, announced today that it has closed a $17M Series C financing. Proceeds from the financing will be used to further expand production capacity in its St. Peters, MO manufacturing facility and fund final development [...]
Join us at the 15th Cytokines & Inflammation Conference, February 6-7, 2017 in San Diego, CA. Booth #6. And check our poster while you’re there: “A Multiplex Panel for Simultaneously Profiling Toxicant Levels and Biological Response Indicators in Serum Samples”.
Adarza BioSystems, Inc. is a venture capital backed biotechnology company developing label-free protein microarray assays based on the Company’s proprietary Arrayed Imaging Reflectometry (AIR™) platform. Adarza is seeking a Quality Manager to implement our QMS and lead the ISO 9001:2015 certification process. Reporting to the Head of Missouri Operations, this individual will have an opportunity [...]
ROCHESTER, N.Y. ST LOUIS, MO – Adarza BioSystems, Inc. a leading next generation innovator in label-free, multiplex assays announced today that it has closed a $5 M Series B financing. Proceeds from the financing will be used to expand production capacity in its St. Peters, MO manufacturing facility and launch its first immunoassay product consumable [...]
Agreement gives Horizon exclusive right to supply services on Ardaza’s multiplex label-free immunoassay technology.
Adarza BioSystems, Inc. has executed an agreement with SunEdison Semiconductor to establish immunoassay consumable manufacturing facilities at its St. Peters, Missouri manufacturing site.
ROCHESTER, NY: Adarza BioSystems, Inc. a leading next generation innovator in label-free, multiplex assays announced today that it has closed the final tranche of its Series-A financing bringing the total Series-A financing amount to $6.8 million. Proceeds from the financing will be used to launch its first 100-plex immunoassay product consumable and instrument and accelerate [...]
Life Science company expands presence to St. Louis ST. LOUIS, MO: BioGenerator recently led syndication of investment in Adarza BioSystems, Inc., to support further commercialization of the company’s immunoassay products. As part of the investment, Adarza will conduct its primary business and product development in St. Louis as well as its manufacturing activities. Adarza is [...]